Operating profit before deduction of amortization: Celldex Therapeutics, Inc. (CLDX)
Celldex Therapeutics (CLDX) develops advanced oncology and inflammation therapies by leveraging its biopharmaceutical expertise. The business is based on unique, first-in-class mast cell inhibitors for skin treatment. The company is currently focusing on organic growth while remaining a promising acquisition target. EBITDA analytics help determine the entry point, and the 0.00 metric confirms the current level of operating profit.
Celldex Therapeutics, Inc. (CLDX) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
- earnings and multiples data:
CLDX - Company Net Income|Expected Profit Celldex Therapeutics|CLDX - P/E Multiple|Price to Future Earnings Ratio celldex.com|CLDX - PEG Multiple|Company Value to EBITDA Celldex Therapeutics|CLDX - Operating profit before deduction of amortization|Earnings per share for the last 12 months Celldex Therapeutics|CLDX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months celldex.com|CLDX - Net earnings per share growth this year|Projected earnings per share increase next year Celldex Therapeutics
Summary company analytics:CLDX - Celldex Corp
Investors are seeking fundamental benchmarks to assess the resilience of biotech assets. This indicator captures the remaining cash balance after deducting all direct operating expenses. By analyzing the EBITDA metric, one can evaluate capital management efficiency during the development phase. For Celldex Therapeutics (CLDX), this reflects the ability to fund the creation of unique mast cell modulators without external support. The stability of this metric confirms the viability of the closed therapeutic protocol.
Who Celldex Therapeutics competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Profit before interest, taxes and amortization|Vera Pharma - Operating profit EBITDA|Dianthus Corp (DNTH) - Operating profit before deduction of amortization|PHVS: Operating profit EBITDA|Profit before interest, taxes and amortization AbCellera (ABCL)|Profit before payment of interest, taxes and amortization Tourmaline Bio|Profit before payment of interest, taxes and amortization PGEN|Profit before payment of interest, taxes and amortization Pharming (PHAR)|Profit before payment of interest, taxes and amortization NKTR (Nektar Corp)|Operating profit EBITDA UPB (Upstream Bio Inc)|ZBIO: Operating profit before amortization|Immunome - Operating profit EBITDA|Profit before interest, taxes and amortization Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Operating profit before deduction of amortization|Operating profit before amortization SEPN|Operating profit before deduction of amortization PVLA|SVRA: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization RIGL (Rigel Pharmaceuticals, Inc.)|Company profit before taxes, interest and amortization ANAB|Operating profit EBITDA ATXS (Astria Pharma)|Income before deduction of interest, taxes and amortization ENGN|RAPT Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization Aerovate Therapeutics Inc|Aclaris Therapeutics, Inc. (ACRS) - Profit before payment of interest, taxes and amortization|Kyverna Therapeutics Inc. - Income before deduction of interest, taxes and amortization|TLSA (Tiziana Life Sciences PLC) - Operating profit EBITDA|Operating profit EBITDA Cabaletta Bio Inc|Profit before payment of interest, taxes and amortization Ventyx Biosciences (VTYX)|THTX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA AVTX (Avalo Therapeutics)|Eledon Pharmaceuticals Inc. (ELDN) - Profit before interest, taxes and amortization|AGEN: Operating profit before deduction of amortization|CLYM - Operating profit EBITDA|ZURA (Zura Bio) - Operating profit before deduction of amortization|ATYR: Company profit before taxes, interest and amortization|ADAG (Adagene Inc) - Operating profit EBITDA|Ikena Oncology, Inc. (IMA) - Operating income before deduction of amortization|Operating profit EBITDA STTK|Operating profit before deduction of amortization equilliumbio.com EQ|Profit before payment of interest, taxes and amortization Connect Biopharma Holdings Limited CNTB|Operating income before deduction of amortization Immunic Therapeutics (IMUX)|Atara Biotherapeutics Inc - Operating profit EBITDA|InflaRx N.V. (IFRX) - Operating profit before deduction of amortization|X4 Pharma (XFOR) - Profit before payment of interest, taxes and amortization|ACET (Adicet Bio, Inc.) - Profit before payment of interest, taxes and amortization|CELU (Celularity Inc) - Operating profit EBITDA|Operating profit before amortization INMB (inmunebio.com)|Operating profit before deduction of amortization BRNS (Barinthus Biotherapeutics plc)|Kezar Life Sciences Inc. - Operating profit before amortization|Profit before payment of interest, taxes and amortization SAB Biotherapeutics, Inc SABS|AKTX (Akari Therapeutics, Plc) - Profit before deduction of interest, taxes, depreciation and amortization|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|Income before deduction of interest, taxes and amortization QTTB (Q32 Bio Inc.)|GOVX: Operating profit EBITDA|Edesa Biotech Inc (EDSA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization iBio Corp|CARM: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization XTL Biopharmaceuticals (XTLB)|Operating profit before deduction of amortization boltbio.com BOLT|Operating profit EBITDA HCWB (HCW Biologics)|Operating profit EBITDA Aptevo Therapeutics, Inc. APVO|AIM: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization ADTX (Aditxt)|GRI: Operating profit EBITDA|XRTX - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Profit before payment of interest, taxes and amortization Indaptus (INDP)|Operating profit before deduction of amortization BiondVax Pharmaceuticals SCNI|CalciMedica - Operating profit before deduction of amortization|Operating profit EBITDA Affimed NV AFMD|ALLK - Profit before payment of interest, taxes and amortization|HOOK (HOOKIPA Pharma Inc.) - Operating profit before amortization|IGMS: Operating profit EBITDA|Profit before interest, taxes and amortization iTeos Pharma (ITOS)|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization tcbiopharm.com (TCBP)|Operating profit EBITDA THRD
